FDA Clearance Tracker · P230001-S005
ColoSense
Last checked: Nov 20, 2026Latest source record: May 14, 2025 (this decision)Source: openFDAMethods & limitations
Decided
May 14, 2025
Approved
Time to decision
264 days
Received Aug 23, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P230001-S005
- Device name
- ColoSense
- Applicant
- Geneoscopy, Inc.
- Applicant location
- St. Louis, MO
- Received
- Aug 23, 2024
- Decided
- May 14, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P230001
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
ColoSense is a qualitative in vitro diagnostic test intended for the detection of colorectal neoplasia associated RNA markers and for the presence of occult hemoglobin in human stool. A positive ColoSense result may indicate the presence of colorectal cancer (CRC), advanced adenomas (AA) or serrated precancerous lesions (SPL) and should be followed by a colonoscopy. ColoSense is indicated as a screening test for adults, 45 years of age or older, who are at average-risk for developing CRC. ColoSense is not a replacement for diagnostic colonoscopy or surveillance colonoscopy in high-risk individuals.
Source documents
Other decisions for Geneoscopy, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- ColoSense®BreakthroughPMA
P230001 · Decided May 3, 2024 · 469 days after receipt
Device type: System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection (SBB) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.